Net revenue for Q1 2026 was $198.3 million, a 7.9% increase from $183.8 million in Q1 2025. Net income attributable to USPH shareholders was $5.0 million, compared to $9.9 million in the prior-year period. Basic and diluted loss per share was $0.12, compared to earnings per share of $0.80 in Q1 2025. Total owned and/or managed clinics reached 783 as of March 31, 2026. The company completed a regional realignment of reporting units effective January 1, 2026.